- Previous Close
12.40 - Open
12.10 - Bid 11.40 x 563500
- Ask 12.30 x 549800
- Day's Range
12.10 - 12.10 - 52 Week Range
11.30 - 14.30 - Volume
65 - Avg. Volume
2 - Market Cap (intraday)
1.043B - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
15.32 - EPS (TTM)
0.79 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield 0.62 (4.98%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
Denka Company Limited manufactures and sells organic and inorganic materials to electronic materials and pharmaceuticals in Japan and internationally. The company's Electronics & Innovative Products division provides conductive agents for lithium for lithium-ion batteries, thermal materials and substrates, functional ceramics, films, and tapes. Its Life Innovation division works to improve people's life in the fields of prevention, diagnosis, and treatment, including influenza vaccines; test reagents, such as rapid testing kits for COVID-19; and macromolecular hyaluronate preparations. The company's Elastomers & Infrastructure Solutions division include functional elastomers, cement and special cement additives, fertilizers, agricultural products. Its Polymer Solutions division consist of styrene-based resins, food packaging sheets, and synthetic fiber for wigs, as well as poval and other chemical products. The company was formerly known as Denki Kagaku Kogyo Kabushiki Kaisha and changed its name to Denka Company Limited in October 2015. Denka Company Limited was incorporated in 1915 and is headquartered in Tokyo, Japan.
www.denka.co.jpRecent News: DIK.F
View MorePerformance Overview: DIK.F
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DIK.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DIK.F
View MoreValuation Measures
Market Cap
1.08B
Enterprise Value
2.13B
Trailing P/E
15.75
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.43
Price/Book (mrq)
0.57
Enterprise Value/Revenue
0.86
Enterprise Value/EBITDA
19.88
Financial Highlights
Profitability and Income Statement
Profit Margin
2.75%
Return on Assets (ttm)
1.22%
Return on Equity (ttm)
3.44%
Revenue (ttm)
398.02B
Net Income Avi to Common (ttm)
10.94B
Diluted EPS (ttm)
0.79
Balance Sheet and Cash Flow
Total Cash (mrq)
43.63B
Total Debt/Equity (mrq)
66.26%
Levered Free Cash Flow (ttm)
--